Kaplonek, Paulina
Cizmeci, Deniz http://orcid.org/0000-0003-3231-7726
Lee, Jessica Shih-Lu
Shin, Sally A. http://orcid.org/0000-0002-9306-2264
Fischinger, Stephanie
Gobeil, Philipe
Pillet, Stéphane
Charland, Nathalie
Ward, Brian J.
Alter, Galit http://orcid.org/0000-0002-7680-9215
Article History
Received: 3 April 2022
Accepted: 27 January 2023
First Online: 13 February 2023
Competing interests
: G.A. is a founder and equity holder for Seromyx Systems Inc., an employee and equity holder for Leyden Labs, and has received financial support from Abbvie, BioNtech, GSK, Gilead, Merck, Moderna, Novartis, Pfizer, and Sanofi. G.A.’s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict-of-interest policies. During the time of the study B.J.W., N.C., and P.G. were either employees of Medicago Inc. or received salary support from Medicago Inc. All other authors have declared that no conflict of interest exists.